Literature DB >> 16989147

The impact of diabetes mellitus on postoperative morbidity in laryngeal surgery.

M Jovanović1, J Perović, A Grubor.   

Abstract

The main aim of this study was to analyse risk factors of postoperative morbidity after extended laryngeal surgery comparing patients with diabetes mellitus and non-diabetic patients. In retrospective study 69 patients (63 male and 6 female), who underwent partial laryngo-pharyngectomy and total laryngectomy between 2003 and 2004, were evaluated. 13 % of the total group of examined patients had concurrent diabetes, while 87% were nondiabetic patients. We performed partial laryngopharyngectomy in 39 out of 69 patients (56.5%) and total laryngectomy in 30 patients (43.5%). Secondary wound infections (88.9%) and pharyngocutaneus fistula (44.5%) had a significantly higher rate in diabetic patients (p<0.001). Among diabetics the cases with intraoperative or postoperative blood transfusions were more frequent--44.4%(p<0.001). Diabetic patients with laryngectomy procedures had more frequently prolonged postoperative anemia (55.5%, p<0.001) and electrolitic disbalance (66.6%, p<0.001). Our results have confirmed that diabetes mellitus is an important independent general clinical factor, which increases postoperative morbidity and hospitalization time in laryngeal surgery. Our data indicate the need to make a very serious plan and clinical assesment for laryngeal surgical therapy in diabetic patients.

Entities:  

Mesh:

Year:  2006        PMID: 16989147     DOI: 10.2298/aci0601051j

Source DB:  PubMed          Journal:  Acta Chir Iugosl        ISSN: 0354-950X


  2 in total

Review 1.  Closure of laryngectomy defects in the age of chemoradiation therapy.

Authors:  Matthew M Hanasono; Derrick Lin; Mark K Wax; Eben L Rosenthal
Journal:  Head Neck       Date:  2011-03-17       Impact factor: 3.147

2.  Multivariate analysis of risk factors for pharyngocutaneous fistula after total laryngectomy.

Authors:  Paolo Boscolo-Rizzo; Giuseppe De Cillis; Carlo Marchiori; Silvia Carpenè; Maria Cristina Da Mosto
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-05       Impact factor: 3.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.